Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.

Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA.

Lancet. 2000 Jun 3;355(9219):1955-60.

PMID:
10859041
2.

Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.

Liu ZS, Jiang CQ, Qian Q, Sun Q, Fan LF, Ai ZL.

Hepatobiliary Pancreat Dis Int. 2002 May;1(2):285-9.

3.

Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis.

Lempinen M, Stenman UH, Finne P, Puolakkainen P, Haapiainen R, Kemppainen E.

J Surg Res. 2003 May 15;111(2):267-73.

PMID:
12850473
4.

A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis.

Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Griñó P, Compañy L, Laveda R, Penalva JC, García C, Pérez-Mateo M.

Pancreas. 2004 Jul;29(1):e9-14.

PMID:
15211118
5.

Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.

Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, McKay C.

Br J Surg. 2004 Aug;91(8):1027-33.

PMID:
15286966
6.

Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

Tenner S, Fernandez-del Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela JE, Hariri M, Hughes M, Banks PA.

Int J Pancreatol. 1997 Apr;21(2):105-10.

PMID:
9209951
7.

Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.

Khan Z, Vlodov J, Horovitz J, Jose RM, Iswara K, Smotkin J, Brown A, Tenner S.

Am J Gastroenterol. 2002 Aug;97(8):1973-7.

PMID:
12190163
9.

Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine.

Lempinen M, Kylänpää-Bäck ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, Korvuo A, Kemppainen E.

Clin Chem. 2001 Dec;47(12):2103-7.

10.

Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.

Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, Shenkin A, Austen BM, Imrie CW, Hermon-Taylor J.

Lancet. 1990 Jan 6;335(8680):4-8.

PMID:
1967341
11.

Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: a meta-analysis.

Huang W, Altaf K, Jin T, Xiong JJ, Wen L, Javed MA, Johnstone M, Xue P, Halloran CM, Xia Q.

World J Gastroenterol. 2013 Jul 28;19(28):4607-15. doi: 10.3748/wjg.v19.i28.4607. Review.

12.

Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis.

Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Compañy L, Laveda R, Griñó P, García C, Pérez-Mateo M.

World J Gastroenterol. 2005 Dec 14;11(46):7261-5.

13.

Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis.

Banks PA, Carr-Locke DL, Slivka A, Van Dam J, Lichtenstein DR, Hughes M.

Pancreas. 1996 Apr;12(3):294-7.

PMID:
8830337
14.

Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.

Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP.

Br J Surg. 2002 Feb;89(2):163-71.

PMID:
11856128
15.
16.

Severe acute pancreatitis is related to increased early urinary levels of the activation Peptide of pancreatic phospholipase A(2).

Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP.

Pancreatology. 2002;2(6):535-42.

PMID:
12435866
17.

Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis.

Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, Notas G, Mouzas I, Samonakis D, Kouroumalis EA.

Pancreas. 2002 Nov;25(4):331-5.

PMID:
12409825
18.
19.

[The value of Ranson and APACHE II scoring systems, and serum levels of interleukin-6 and C-reactive protein in the early diagnosis of the severity of acute pancreatitis].

Gürleyik G, Zahidullahoğlu Cirpici O, Aktekin A, Sağlam A.

Ulus Travma Acil Cerrahi Derg. 2004 Apr;10(2):83-8. Turkish.

PMID:
15103565
20.

Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant.

Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG.

Crit Care Med. 2000 Mar;28(3):736-42.

PMID:
10752823

Supplemental Content

Support Center